top of page
Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder
About the study
NCT Trial Number
The drug being studied
Guangzhou Women and Children's Medical Center
Trial Start Date
About the participants
2 Years to 15 Years ¬† (Child)
Primary condition of volunteers accepted
Accepts healthy volunteers?
This study will determine the efficacy and safety of intranasal ketamine with dexmedetomidine in children with Autism Spectrum Disorder..
Guangzhou Women and Children Medical Center
Guangzhou, Guangdong, China, 510000
Contact: Ying-Jun She, Doctor
bottom of page